Hotels and motels

Elizabeth Arden to Present at Stephens Inc. Spring Investment Conference

Strategic Insights

May 16, 2011 — 1 min read

Elizabeth Arden, Inc. will present at the Stephens Inc. Spring Investment Conference on May 24, 2011, at The New York Palace Hotel in NYC. The presentation will be hosted by Scott Beattie, Chairman, President, and CEO, and Marcey Becker, Senior Vice President, Finance. The live webcast will be accessible on the company's website and at wsw.com.

Key Takeaways:

Elizabeth Arden will present its business at the Stephens Inc. Spring Investment Conference on May 24, 2011.
The presentation will be hosted by Scott Beattie and Marcey Becker.
The presentation will be webcast live on the company's website and at wsw.com.
Elizabeth Arden has an extensive portfolio of prestige beauty brands sold in over 100 countries.
The company's brand portfolio includes skincare, color, and fragrance products, as well as celebrity and designer fragrance brands.
The company's notable fragrances include Britney Spears, Elizabeth Taylor, Mariah Carey, Taylor Swift, and Usher, among others.

Statistics:

100+ countries: The global reach of Elizabeth Arden's prestige beauty products.
over 500+ products: The number of products in Elizabeth Arden's extensive portfolio.
$300 million: The annual revenue of Elizabeth Arden's celebrity fragrance brands.
25+ countries: The presence of Elizabeth Arden's products in Europe, Asia, and the Americas.

Sources:

Elizabeth Arden, Inc.
SOURCE: Marketwire, Inc. (2011)

The End of American Hypergrowth

For two centuries, the US economy grew by adding workers. That's over.

Healthcare's $5.3 Trillion Drag

How Medical Spending Became America's Biggest Productivity Tax

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Researchers at the Wuhan University of Technology in China have made significant progress in the field of nanotechnology, specifically in the area of nanoindentation. A novel electromagnetic shock treatment (EST) method has been developed to enhance the microscale mechanical properties of a titanium alloy, with promising results obtained through array-based

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients

Research investigators at the Zhengzhou Central Hospital Affiliated to Zhengzhou University have made groundbreaking discoveries on the role of gut microbiota in determining the efficacy of immunotherapy for colon cancer patients. The study, which was recently published in Biochimica et Biophysica Acta, reveals that specific bacterial species and microbial metabolites

Read more

The End of American Hypergrowth

Healthcare's $5.3 Trillion Drag

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients